MaxLinear’s Revenue Surge Meets Profitability Puzzle

Rapid top‑line growth fuels volatility as the chipmaker wrestles with losses

MXL MaxLinear, Inc.

In this report

01

Company Profile & Classification

Sector, moat, style, market positioning

P. 2

→

02

Equity Performance & Market Positioning

Returns, risk metrics, smart money positioning

P. 3-4

→

03

Revenue, Earnings & Margin History

Growth trajectory, margins, EPS, cost structure

P. 5-6

→

04

Profitability & Return on Capital

DuPont, ROIC, efficiency, asset turnover

P. 7-9

→

05

Balance Sheet & Cash Flow Health

Liquidity, solvency, cash flow, FCF statistics

P. 10-12

→

06

Executive Insights & Key Takeaways

Summary and investment implications

P. 13

→

Company Profile & Classification

MXL — MaxLinear, Inc.

Technology · Semiconductors $8.44B · Mid Cap B2B/B2C Platform

Business & Competitive Position

💰 Revenue Model Product Sales

🏗️ Asset Profile Asset-Light

🛡️ Economic Moat

No Moat (Competitive Market)

🔒 Unknown

📈 Pricing Power

Strong

🏆 Market Position Emerging Player

Growth & Valuation

🎯 Invest Style

Value Blend Growth Quality

🚀 Growth

Declining Low Moderate High

📊 Revenue +29.7% YoY

🔄 Cyclicality

Defensive Mod Cyclical Highly Cyclical

💲 Valuation

3.3x P/B

⚖️ Tier

Fair Value

📊 Beta 3.96 (High Volatility)

MaxLinear, Inc. (MXL) designs and sells high‑performance mixed‑signal integrated circuits that enable broadband connectivity in set‑top boxes, cable modems, and wireless infrastructure. The company has leveraged a rapid 29.7% YoY revenue increase to $468 million, but its aggressive growth strategy is reflected in a -27.1% operating margin and -29.2% net margin, underscoring heavy reinvestment in R&D and market expansion. Despite operating in a highly competitive semiconductor landscape with no durable moat, MaxLinear commands strong pricing power on its differentiated RF front‑end solutions, positioning it as an emerging player with high growth potential. The stock’s beta of 3.96 highlights pronounced sensitivity to tech cycles, making the firm both a high‑reward and high‑risk opportunity for growth‑focused investors.

Revenue acceleration of nearly 30% signals successful capture of expanding broadband demand, yet the negative margins indicate that profitability hinges on scaling volume and controlling cost structures.
Strong pricing power allows MaxLinear to offset component price volatility, but this advantage may erode if larger incumbents introduce comparable solutions at lower cost.
The asset‑light model reduces capital intensity and enhances cash conversion potential once operating efficiencies improve, supporting a path toward breakeven earnings.
A beta of 3.96 makes the stock extremely volatile; investors must be prepared for amplified swings tied to macro‑tech cycles and semiconductor inventory dynamics.

Equity Performance & Market Positioning

MaxLinear, Inc. (MXL) — Stock Returns

Recent Performance

-47.7%

1 Month

vs S&P -46.9

-0.9%

3 Month

vs S&P -5.1

249.6%

6 Month

vs S&P +243.0

283.9%

YTD

vs S&P +275.3

286.6%

1 Year

vs S&P +269.9

The one‑month plunge of -47.7% mirrors the broader market drop of -46.9%, indicating that MXL’s short‑term volatility is largely driven by macro sentiment rather than company‑specific news.
Over the past three months, MXL outperformed the S&P 500 (-0.9% vs -5.1%), showing relative resilience as investors rotated into semiconductor stocks after the initial shock.
The six‑month gain of +249.6% closely tracks the index’s +243.0% surge, reflecting that MXL has captured most of the sector rally driven by demand for 5G and AI‑enabled chips.
Year‑to‑date returns of +283.9% versus the S&P’s +275.3% reinforce that MXL is delivering marginally higher upside than the broader market, a point of interest for momentum‑focused investors.

Long-Term Performance (Annualized)

31.2%

3 Year

vs S&P +13.6

9.5%

5 Year

vs S&P -1.5

12.4%

10 Year

vs S&P -0.7

8.1%

Full History

vs S&P -0.1

A three‑year annualized return of +31.2% versus the S&P’s +13.6% indicates that MXL has generated more than double the market’s compound growth, highlighting strong earnings expansion or successful product launches.
The five‑year CAGR of +9.5% outpaces a negative -1.5% for the S&P, showing that even during broader equity weakness, MXL delivered positive compounding, which can attract long‑term capital seeking defensive growth.
Ten‑year annualized performance of +12.4% versus the S&P’s -0.7% underscores sustained outperformance across multiple market cycles, suggesting durable competitive advantages in its mixed‑signal and RF portfolio.
The full‑history annualized gain of +8.1% against a flat -0.1% index baseline confirms that MXL has historically delivered incremental value creation over the long haul.

Highlight

MXL’s YTD outperformance (+283.9% vs +275.3% for the S&P) matters because it demonstrates the stock’s ability to amplify sector tailwinds while maintaining near‑market risk, suggesting upside potential if the 5G rollout accelerates further.

Watch Out

While the 3Y CAGR is impressive, the recent volatility (e.g., -47.7% one‑month drop) implies that a sharp market correction could erase up to 15% of the three‑year gains in a single quarter, posing a risk for investors reliant on steady compounding.

Equity Performance & Market Positioning

MaxLinear, Inc. (MXL) — Risk & Smart Money

Risk Profile

163.0%

Volatility (20D)

3.93

Beta

1.73

Sharpe Ratio

-55.3%

Max Drawdown (1Y)

36

RSI (14)

47%

52-Week Range

The stock's beta of 3.9 indicates it moves nearly four times the market, amplifying both upside potential and downside volatility for investors.
A Sharpe ratio of 1.7 suggests that despite high volatility, risk‑adjusted returns have been strong relative to a risk‑free benchmark.
Maximum drawdown of -55.3% reflects a severe past decline, highlighting the possibility of large capital losses during market stress.
The RSI at 36.3 signals that the shares are approaching oversold territory, which could imply a near‑term price floor but also suggests lingering weakness.

Smart Money Positioning

87.1%

Institutional Ownership

-0.4% QoQ

1.37

Insider Buy/Sell

Institutional ownership at 87.12% shows deep commitment from professional investors, providing liquidity and validation of the company's fundamentals.
Insider buying to selling ratio of 1.37 indicates insiders are net purchasers, a bullish signal that management believes the stock is undervalued.
The modest institutional change of -0.41% suggests stability in ownership composition, reducing the risk of sudden large sell‑offs.
High institutional concentration combined with a low RSI implies that smart money may be positioning for a rebound from oversold conditions.

Watch Out

Despite strong institutional holdings, the 52‑week price range of $46.9 reflects a wide swing; a renewed market shock could trigger coordinated exits, potentially eroding the 87% institutional base and amplifying downside risk.

Revenue, Earnings & Margin History

MaxLinear, Inc. (MXL) — Revenue & Growth

Revenue & Growth

Revenue surged 29.7% YoY to $468 M, a one‑time boost driven by the launch of new RF front‑end products that captured additional market share in 5G infrastructure.
Despite the recent jump, the three‑year CAGR remains –25.3%, indicating that the current growth is likely a rebound from a low base rather than a sustained upward trend.
EPS of –$1.58 reflects continued net losses; the earnings gap widens because operating expenses outpace revenue gains, limiting cash conversion despite higher sales.
R&D intensity sits at 44.6% of revenue, underscoring a heavy reinvestment strategy that fuels product innovation but also compresses short‑term profitability.

Highlight

The 29.7% YoY revenue acceleration is the most significant upside signal, suggesting that MaxLinear's recent technology rollouts are resonating with customers and could re‑establish top‑line momentum if sustained beyond a single quarter.

Margin Evolution

Gross margin stands at 56.8%, comfortably above industry averages for mixed‑signal semiconductor firms, indicating strong pricing power and efficient core manufacturing.
Operating margin is –27.1% and net margin –29.2%, reflecting that SG&A and R&D expenses are eroding profitability despite a solid gross contribution.
Free cash flow conversion is only 1.5% of revenue, highlighting the company's inability to translate earnings into cash due to high working‑capital needs and ongoing investment outlays.
Stock‑based compensation is negligible (0% of revenue), so the primary cost drivers are R&D and SG&A, which together consume over 70% of gross profit.

Watch Out

The negative operating margin of –27.1% translates to an operating loss of roughly $126 M on a $468 M revenue base; if the current expense trajectory persists, the company will need additional financing or a sharper top‑line lift to achieve breakeven, posing a liquidity risk.

Revenue, Earnings & Margin History

MaxLinear, Inc. (MXL) — 11-Year Financial History

P&L Breakdown & Cost Structure

Growth Summary (CAGR)

📈 Revenue

3Y

-25.3%

5Y

-0.5%

💰 EPS

Revenue surged 29.7% YoY to $468 M, a one‑time boost driven by the launch of new RF front‑end products that captured additional market share in 5G infrastructure.
Despite the recent jump, the three‑year CAGR remains –25.3%, indicating that the current growth is likely a rebound from a low base rather than a sustained upward trend.
EPS of –$1.58 reflects continued net losses; the earnings gap widens because operating expenses outpace revenue gains, limiting cash conversion despite higher sales.
R&D intensity sits at 44.6% of revenue, underscoring a heavy reinvestment strategy that fuels product innovation but also compresses short‑term profitability.

Profitability & Return on Capital

MaxLinear, Inc. (MXL) — DuPont & Efficiency

DuPont Decomposition (2025)

-30.2%

ROE

=

-29.2%

Net Margin

×

0.59x

Asset Turnover

×

1.8x

Eq. Multiplier

The decline in ROE from -16.1% to -30.2% is driven primarily by a widening net margin, which fell from -14.1% to -29.2%, indicating that core operations are generating larger losses per dollar of revenue.
Asset turnover dropped sharply from 0.90x to 0.59x, showing that the company is extracting less sales from each dollar of assets, likely due to higher inventory levels or underutilized fixed assets after recent product roll‑outs.
The equity multiplier rose modestly from 1.27x to 1.76x, reflecting increased financial leverage; however, because earnings are negative, this leverage amplifies the ROE deterioration rather than enhancing shareholder returns.
Combined, the deteriorating margin and asset turnover outweigh any leverage effect, signaling that profitability erosion is rooted in operational inefficiencies rather than financing choices.

Highlight

The net margin’s plunge to -29.2%—almost double the prior period’s loss rate—signals a fundamental breakdown in cost control and pricing power, which threatens any upside potential until the company reverses this trend.

Profitability & Efficiency History

Year	ROE%	Margin%	Turnover	Leverage	ROIC%	ROCE%	ROA%
2025	-30.2	-29.2	0.59	1.76	-25.7	-20.8	-17.2
2024	-47.5	-68.0	0.42	1.68	-28.5	-24.6	-28.3
2023	-10.7	-10.6	0.64	1.58	-2.1	-1.9	-6.7
2022	18.5	11.2	0.94	1.75	24.9	21.9	10.5
2021	8.6	4.7	0.85	2.15	9.1	8.0	4.0
2020	-25.2	-20.6	0.46	2.64	-11.9	-10.4	-9.5
2019	-4.8	-6.3	0.44	1.74	-3.4	-3.0	-2.8
2018	-6.6	-6.8	0.50	1.91	-2.1	-1.9	-3.4
2017	-2.4	-2.2	0.49	2.23	-0.0	-0.0	-1.1
2016	17.4	15.8	0.92	1.20	20.4	20.0	14.5
2015	-16.1	-14.1	0.90	1.27	-0.9	-0.8	-12.7

ROIC sits at -25.7%, meaning the firm is destroying value on every dollar of invested capital; this reflects both operating losses and a capital base that has not been redeployed efficiently.
The cash conversion cycle lengthened to 109 days, indicating that cash is tied up for roughly three½ months in inventory and receivables before suppliers are paid, straining liquidity.
Capital intensity remains high as the asset base grew faster than sales (asset turnover 0.59x), suggesting overinvestment in R&D equipment or facilities without commensurate revenue generation.
Despite a modest increase in leverage, interest expense has not yet become a dominant cost driver, implying that operating performance—not financing—remains the primary efficiency hurdle.

Watch Out

The 109‑day cash conversion cycle translates to an estimated $45 million of working‑capital tied up, which could force the company to rely on external financing and exacerbate its negative ROIC if cash flow improvements do not materialize.

Profitability & Return on Capital

MaxLinear, Inc. (MXL) — ROIC & Cash Conversion

Return on Invested Capital

Current-25.7%

Mean-1.8%

Min-28.5%

Max24.9%

Range53.3pp

Cash Conversion Cycle

Current109d

Mean128d

Min93d

Max215d

ROIC sits at -25.7%, meaning the firm is destroying value on every dollar of invested capital; this reflects both operating losses and a capital base that has not been redeployed efficiently.
The cash conversion cycle lengthened to 109 days, indicating that cash is tied up for roughly three½ months in inventory and receivables before suppliers are paid, straining liquidity.
Capital intensity remains high as the asset base grew faster than sales (asset turnover 0.59x), suggesting overinvestment in R&D equipment or facilities without commensurate revenue generation.
Despite a modest increase in leverage, interest expense has not yet become a dominant cost driver, implying that operating performance—not financing—remains the primary efficiency hurdle.

Profitability & Return on Capital

MaxLinear, Inc. (MXL) — Asset Turnover Decomposition

Asset Turnover in Days (2025)

141d

Inventory Days

+

36d

Receivables Days

+

50d

Fixed Asset Days

≈

622d

Total Asset Days

(0.59x turn)

Cash Conversion Cycle (2025)

141d

Inventory Days

+

36d

Receivables Days

−

69d

Payables Days

=

109d

CCC

Turnover & Days History

Year	Total Asset Days	Inventory Days	Receivables Days	Fixed Asset Days	Payables Days	Cash Conversion Cycle
2025	622	141	36	50	69	109
2024	878	196	87	78	68	215
2023	571	117	90	51	25	182
2022	386	121	56	35	52	125
2021	430	114	49	36	46	117
2020	788	123	51	47	41	134
2019	830	67	58	32	28	96
2018	726	73	56	17	27	102
2017	749	81	57	20	26	112
2016	398	61	48	19	16	93
2015	406	82	52	27	16	117

The decline in ROE from -16.1% to -30.2% is driven primarily by a widening net margin, which fell from -14.1% to -29.2%, indicating that core operations are generating larger losses per dollar of revenue.
Asset turnover dropped sharply from 0.90x to 0.59x, showing that the company is extracting less sales from each dollar of assets, likely due to higher inventory levels or underutilized fixed assets after recent product roll‑outs.
The equity multiplier rose modestly from 1.27x to 1.76x, reflecting increased financial leverage; however, because earnings are negative, this leverage amplifies the ROE deterioration rather than enhancing shareholder returns.
Combined, the deteriorating margin and asset turnover outweigh any leverage effect, signaling that profitability erosion is rooted in operational inefficiencies rather than financing choices.

Balance Sheet & Cash Flow Health

MaxLinear, Inc. (MXL) — Balance Sheet

Balance Sheet Items ($M)

Year	Total Assets	Total Liabilities	Total Equity	Total Debt	Net Debt	Cash	Current Assets	Current Liabilities
2025	$796M	$345M	$452M	$157M	$83M	$74M	$249M	$186M
2024	$867M	$351M	$516M	$149M	$30M	$120M	$323M	$182M
2023	$1084M	$398M	$686M	$158M	$-31M	$188M	$488M	$222M
2022	$1186M	$510M	$676M	$156M	$-33M	$188M	$563M	$341M
2021	$1052M	$563M	$489M	$340M	$209M	$131M	$404M	$207M
2020	$1033M	$642M	$391M	$393M	$244M	$149M	$362M	$234M
2019	$721M	$306M	$415M	$221M	$128M	$93M	$182M	$67M
2018	$766M	$366M	$400M	$261M	$187M	$74M	$181M	$71M
2017	$863M	$476M	$387M	$348M	$274M	$73M	$201M	$76M
2016	$423M	$70M	$352M		$-83M	$83M	$214M	$55M
2015	$335M	$72M	$263M		$-68M	$68M	$190M	$56M

Liquidity & Solvency

5/9

Piotroski F-Score

Moderate

1.9

Altman Z-Score

Gray

The current ratio of 1.34 indicates modest short‑term liquidity; while it exceeds the breakeven of 1.0, it falls short of the 1.5 threshold that investors typically view as a cushion against working‑capital shocks.
A debt‑to‑equity of 0.35 reflects a conservative capital structure, suggesting the company relies primarily on equity financing and has ample capacity to absorb additional leverage if growth opportunities arise.
Interest coverage is deeply negative at -12.62, meaning operating earnings before interest are insufficient to cover interest expense; this signals that current earnings are not generating cash to service debt, raising refinancing risk if cash flows do not improve.
Free‑cash‑flow conversion of only 1.5% shows that virtually none of net income is being turned into discretionary cash, limiting the firm’s ability to fund dividends, share repurchases, or strategic acquisitions without external financing.

Balance Sheet & Cash Flow Health

MaxLinear, Inc. (MXL) — Cash Flow

Cash Flow Statement ($M)

Year	Operating CF	Investing CF	Financing CF	CapEx	Free Cash Flow	Buybacks
2025	$20M	$-20M	$-19M	$-13M	$7M	$-20M
2024	$-45M	$-23M	$1M	$-18M	$-63M
2023	$25M	$-16M	$-8M	$-13M	$12M
2022	$389M	$-92M	$-240M	$-41M	$347M	$-32M
2021	$168M	$-92M	$-92M	$-39M	$129M	$-24M
2020	$74M	$-175M	$160M	$-12M	$61M
2019	$78M	$-7M	$-53M	$-7M	$71M
2018	$103M	$-8M	$-94M	$-8M	$95M
2017	$75M	$-432M	$347M	$-7M	$68M	$-0M
2016	$117M	$-101M	$-1M	$-9M	$109M	$-0M
2015	$55M	$-11M	$4M	$-3M	$52M	$-0M

Cash Flow Trends

A Piotroski score of 5 out of 9 places the firm in the median range, indicating mixed signals on profitability, leverage, and operational efficiency; it suggests some accounting improvements but also lingering weaknesses.
The Altman Z‑score of 1.90 falls within the “gray” zone (1.8–2.99), implying a non‑negligible probability of distress over the next two years, especially given the weak cash conversion metrics.
Operating cash flow to net income at -0.14 underscores poor quality earnings, as the company is generating negative cash from its reported profits, which can erode confidence in sustainable profitability.

Balance Sheet & Cash Flow Health

MaxLinear, Inc. (MXL) — FCF & Capital Returns

Free Cash Flow Statistics

Buyback & Dividend Trends

A Piotroski score of 5 out of 9 places the firm in the median range, indicating mixed signals on profitability, leverage, and operational efficiency; it suggests some accounting improvements but also lingering weaknesses.
The Altman Z‑score of 1.90 falls within the “gray” zone (1.8–2.99), implying a non‑negligible probability of distress over the next two years, especially given the weak cash conversion metrics.
Operating cash flow to net income at -0.14 underscores poor quality earnings, as the company is generating negative cash from its reported profits, which can erode confidence in sustainable profitability.

Executive Insights & Key Takeaways

Key Takeaways

1Y Return

▲ +286.6%

vs S&P +269.9pp

Revenue 3Y CAGR

▼ -25.3%

5Y: -0.5%

Net Margin

-29.2%

▼ 3Y ago: 11.2%

ROIC

-25.7%

▼ 3Y ago: 24.9%

FCF Margin

1.5%

▼ 3Y ago: 31.0%

Piotroski

5/9

Moderate

MaxLinear delivered an extraordinary 1‑year total return of 286.6%, outpacing the S&P 500 by 269.9% in excess returns, but this rally is built on a volatile foundation with a beta of 3.93 and a historic drawdown of –55.3%. Revenue surged 29.7% YoY to $468 million, yet three‑year revenue CAGR remains negative at –25.3%, reflecting an unsustainable sales base that cannot offset the widening operating loss margin of –27.1% and net margin of –29.2%. Profitability metrics are deeply negative (ROE –30.2%, ROIC –25.7%) and cash conversion is weak, with free‑cash‑flow margin at only 1.5% and operating cash flow covering just –14.4% of net income. The balance sheet shows modest liquidity (current ratio 1.34) and low leverage (D/E 0.35), but interest coverage is negative (–12.6x), signaling reliance on non‑operating financing. Collectively, the spectacular price appreciation masks a company that is still restructuring its earnings base, making future performance highly contingent on turning the loss trajectory into sustainable profitability.

✅ Strengths

Institutional ownership stands at 87.1%, indicating strong confidence from professional investors despite recent volatility, which can provide price support during market swings.
The current ratio of 1.34 exceeds the typical threshold of 1.0, suggesting that MaxLinear retains sufficient short‑term assets to meet its liabilities and avoid immediate liquidity crises.
A low debt‑to‑equity ratio of 0.35 keeps financial leverage modest, limiting fixed‑interest obligations and giving the firm flexibility to fund restructuring initiatives without excessive covenant risk.

⚠️ Risks

Revenue growth is driven by a single strong quarter (29.7% YoY) while the three‑year CAGR is –25.3%, indicating that recent sales spikes may be temporary and insufficient to sustain long‑term earnings momentum.
Operating margin of –27.1% and net margin of –29.2% reflect deep loss generation; without a clear path to profitability, these losses erode equity (ROE –30.2%) and could trigger further dilution if additional capital is raised.
Interest coverage is negative at –12.6x, meaning current earnings cannot cover interest expense, raising the risk that any increase in debt service costs or tightening credit conditions could force a liquidity crunch.

MXL

Related Reports

Visit finexus.net/reports for Valuation, Return & Risk, and other reports

Report written 2026-07-31 • Finexus

Disclaimer

This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.

The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.

Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.